Welcome to India's first Website with complete information on Infectious deseases, Vaccines, Immunisation and Immunoglobulins. + + + Become a registered member of the site and recieve latest balanced information from the world of Vaccines.
PDF Print E-mail

Identifying and Caring For Patients

 

Transmission

Transmission of novel influenza A (H1N1) is being studied as part of the ongoing outbreak investigation, but limited data available indicate that this virus is transmitted in ways similar to other influenza viruses. Seasonal human influenza viruses are thought to spread from person to person primarily through large-particle respiratory droplet transmission (e.g., when an infected person coughs or sneezes near a susceptible person). Transmission via large-particle droplets requires close contact between source and recipient persons because droplets do not remain suspended in the air and generally travel only a short distance (< 6 feet). Contact with contaminated surfaces is another possible source of transmission and transmission via droplet nuclei (also called “airborne” transmission). Because data on the transmission of novel H1N1 viruses are limited, the potential for ocular, conjunctival, or gastrointestinal infection is unknown. Since this is a novel influenza A virus in humans, transmission from infected persons to close contacts might be common. All respiratory secretions and bodily fluids (diarrheal stool) of novel influenza A (H1N1) cases should be considered potentially infectious.

Incubation period

The estimated incubation period is unknown and could range from 1-7 days, and more likely 1-4 days.

Persons with confirmed novel influenza A (H1N1) virus infection

View the Case definitions for Confirmed, Probable and Suspected cases.

Clinical findings

Patients with uncomplicated disease due to confirmed novel influenza A (H1N1) virus infection have experienced fever, chills, headache, upper respiratory tract symptoms (cough, sore throat, rhinorrhea, shortness of breath), myalgias, arthralgias, fatigue, vomiting, or diarrhea. In New York City, 95% of patients with novel influenza A (H1N1) met the case definition for influenza-like illness (subjective fever plus cough and/or sore throat) 

Complications

There is insufficient information to date about clinical complications of this novel influenza A (H1N1) virus infection. Among persons infected with previous variants of swine influenza viruses, clinical syndromes have ranged from mild respiratory illness, to lower respiratory tract illness, dehydration, or pneumonia. Deaths caused by previous variants of swine influenza viruses have occasionally occurred. Although data on the spectrum of illness is not yet available for this novel influenza A (H1N1), clinicians should expect complications to be similar to seasonal influenza: exacerbation of underlying chronic medical conditions, upper respiratory tract disease (sinusitis, otitis media, croup) lower respiratory tract disease (pneumonia, bronchiolitis, status asthmaticus), cardiac (myocarditis, pericarditis), musculoskeletal (myositis, rhabdomyolysis), neurologic (acute and post-infectious encephalopathy, encephalitis, febrile seizures, status epilepticus), toxic shock syndrome, and secondary bacterial pneumonia with or without sepsis.

Groups at high risk for complications

Currently, insufficient data are available to determine who is at higher risk for complications of novel influenza A (H1N1) virus infection. Thus, at this time, the same age and risk groups who are at higher risk for seasonal influenza complications should also be considered at higher risk for swine-origin influenza complications.

Groups at higher risk for seasonal influenza complications include:

  • Children less than 5 years old;
  • Persons aged 65 years or older;
  • Children and adolescents (less than 18 years) who are receiving long-term aspirin therapy and who might be at risk for experiencing Reye syndrome after influenza virus infection;
  • Pregnant women;
  • Adults and children who have chronic pulmonary, cardiovascular, hepatic, hematological, neurologic, neuromuscular, or metabolic disorders;
  • Adults and children who have immunosuppression (including immunosuppression caused by medications or by HIV);
  • Residents of nursing homes and other chronic-care facilities.

Medical care for patients with novel influenza A (H1N1) virus

Not all patients with suspected novel influenza (H1N1) infection need to be seen by a health care provider. Patients with severe illness and those at high risk for complications from influenza (see list above) should contact their medical provider or seek medical care.

Which patients should be tested for novel influenza A (H1N1) virus

Clinicians should test persons for the novel influenza (H1N1) virus if they have an acute febrile respiratory illness or sepsis-like syndrome. Certain groups may have atypical presentations including infants, elderly and persons with compromised immune systems. Priority for testing includes persons who 1) require hospitalization or 2) are at high-risk for severe disease (as listed above). To test for novel H1N1 influenza virus, upper respiratory specimens, such as a nasopharyngeal swab or aspirate, nasal swab plus a throat swab or nasal wash, or tracheal aspirate should be collected. Persons who perform nasal and tracheal aspirate collections on ill persons require appropriate personal protective equipment. Specimens should be sent to the state public health laboratory. Not all people with suspected novel influenza (H1N1) infection need to have the diagnosis confirmed, especially if the person resides in an affected area or if the illness is mild. Recommendations on who to test may differ by state or community. Clinicians should be aware of local guidance on testing and should use their clinical judgment in addition to this guidance for deciding when to test for novel influenza A (H1N1). View the Interim guidance on specimen collection, processing, and testing.

Reporting suspect novel influenza A (H1N1) virus infection

Clinicians should contact their state public health department if they test a person for novel influenza A (H1N1) infection to obtain information on what clinical and epidemiological data to collect and specimen shipment protocols in their state. See also Information on laboratory testing and specimen collection.

Treatment of novel influenza A (H1N1)

The novel influenza (H1N1) virus is susceptible to both oseltamivir and zanamivir. It is resistant to amantadine and rimantadine. View Interim guidance on antiviral treatment for novel influenza A (H1N1).

Additional Therapy

Additional therapy such as antibacterial agents, should be used at the discretion of the clinicians given the patients clinical presentation. For antibacterial treatment of pneumonia, clinical guidance for community-acquired pneumonia should be followed and can be accessed here.

For hospitalized patients with severe community-acquired pneumonia (CAP) requiring intensive care unit admission, menthicillin-resistent Staphylococcus aureus (MRSA) infection should be suspected and treated empirically in addition to other causes of CAP if they have 1) necrotizing or cavitary infiltrates or 2) empyema.

Infectious period

The duration of shedding with novel influenza A (h1N1) virus is unknown. Therefore, until data are available, the estimated duration of viral shedding is based upon seasonal influenza virus infection.. Infected persons are assumed to be shedding virus from one day prior to illness onset until resolution of symptoms. In general, persons with novel influenza A (H1N1) virus infection should be considered potentially infectious from one day before to 7 days following illness onset. Children, especially younger children, might be infectious for up to 10 days.

Infection control measures

 

View the guidance on infection control during care of patients with confirmed or suspected novel influenza A (H1N1) virus infection.

Antiviral chemoprophylaxis

View the guidance on pre-exposure and post-exposure chemoprophylaxis with antiviral agents for novel influenza A (H1N1) virus can be found at

 

 

Comments   

 
Antje
0 # Identifying and Caring For PatientsAntje 2014-05-27 16:43
Hi there! I could have sworn I've visited this site before
but after browsing through a few of the posts I realized
it's new to me. Anyways, I'm certainly pleased I came across it and I'll be book-marking it and checking back often!

Here is my homepage - nike free kopen: [censored]:[cen sored][censored ]tinyurl.com[ce nsored]ojfl274
Reply | Reply with quote | Quote
 
 
Garfield
0 # Identifying and Caring For PatientsGarfield 2014-06-06 16:27
I savor, result in I found exactly what I was having
a look for. You have ended my four day lengthy hunt!
God Bless you man. Have a great day. Bye

my homepage ... Pure Yacon Supplement: [censored]:[cen sored][censored ]u.3puok.com[ce nsored]space.ph p?uid=149564&do =blog&id=109513
Reply | Reply with quote | Quote
 
 
Clifford
0 # Identifying and Caring For PatientsClifford 2014-07-03 03:17
I have read so many posts on the topic off the blogger lovers however this
piec e of writing is truly a fastidious piece
of writing, keep it up.

Take a look at my homepage - naturalremedies forsorethroat: [censored]:[cen sored][censored ]www.naturalrem ediesforsorethr oat.com[censore d]
Reply | Reply with quote | Quote
 
 
Clemmie
0 # Identifying and Caring For PatientsClemmie 2014-07-03 17:01
Hi just wanted to give you a quick heads up and
let you know a few of the images aren't loading properly.
I'm not sure why but I think its a linking issue.
I've tried it in two different internet browsers and both show the same outcome.


My website; fifa world cup 2014 squads: [censored]:[cen sored][censored ]www.footballwo rldcup2014.in[c ensored]
Reply | Reply with quote | Quote
 
 
Ellis
0 # Identifying and Caring For PatientsEllis 2014-08-04 17:18
Wonderful, what a blog it is! This webpage provides valuable information to us,
keep it up.

Have a look at my homepage: chris landry mortgage broker: [censored]:[cen sored][censored ]burnaby.yalwa. ca[censored]ID_ 133138401[censo red]Chris-Landr y-Mortgage-Brok er.html
Reply | Reply with quote | Quote
 
 
Coy
0 # Identifying and Caring For PatientsCoy 2015-02-16 00:35
Hi pipls!

Feel free to visit my web-site ... [censored] [censored]: [censored]:[cen sored][censored ]buyedtablets[c ensored]24-7.co m
Reply | Reply with quote | Quote
 
 
Lucie
0 # Identifying and Caring For PatientsLucie 2015-02-16 02:44
Hi pipls!

My homepage - [censored]
[cen sored]: [censored]:[cen sored][censored ]buyedtablets[c ensored]24-7.co m
Reply | Reply with quote | Quote
 
 
Veronique
0 # Identifying and Caring For PatientsVeronique 2015-02-16 09:31
Hi pipls!

Here is my web blog [censored]: [censored]:[cen sored][censored ]buyedtablets[c ensored]24-7.co m
Reply | Reply with quote | Quote
 
 
Sue
0 # Identifying and Caring For PatientsSue 2015-02-16 11:48
Hi pipls!

My blog :: [censored] [censored]: [censored]:[cen sored][censored ]buyedtablets[c ensored]24-7.co m
Reply | Reply with quote | Quote
 
 
Phillis
0 # Identifying and Caring For PatientsPhillis 2015-02-16 18:26
Hi pipls!

my homepage; [censored] [censored]: [censored]:[cen sored][censored ]buyedtablets[c ensored]24-7.co m
Reply | Reply with quote | Quote
 
 
Jeremy
0 # Identifying and Caring For PatientsJeremy 2015-02-16 20:39
Hi pipls!

Visi t my web blog - [censored] [censored]: [censored]:[cen sored][censored ]buyedtablets[c ensored]24-7.co m
Reply | Reply with quote | Quote
 
 
Ivy
0 # Identifying and Caring For PatientsIvy 2015-02-17 03:30
Hi pipls!

My weblog :: [censored] [censored]: [censored]:[cen sored][censored ]buyedtablets[c ensored]24-7.co m
Reply | Reply with quote | Quote
 
 
Maricruz
0 # Identifying and Caring For PatientsMaricruz 2015-02-17 12:42
Hi pipls!

Look into my weblog - [censored] [censored]: [censored]:[cen sored][censored ]buyedtablets[c ensored]24-7.co m
Reply | Reply with quote | Quote
 
 
Iva
0 # Identifying and Caring For PatientsIva 2015-02-22 04:59
Hi pipls!

Also visit my site; [censored] [censored]: [censored]:[cen sored][censored ]buyedtablets[c ensored]24-7.co m
Reply | Reply with quote | Quote
 
 
Kami
0 # Identifying and Caring For PatientsKami 2015-10-10 07:09
First of all I want to say wonderful blog!
I had a quick question which I'd like to ask if you do not mind.
I was interested to know how you center yourself and clear your mind before writing.
I have had difficulty clearing my mind in getting my thoughts out.
I do enjoy writing however it just seems like the first 10 to 15 minutes
tend to be lost simply just trying to figure out how to begin. Any recommendations or tips?

Than k you!

Look at my web-site: bolsas plastico
vale ncia: [censored]s:[ce nsored][censore d]youtube.com[c ensored]watch?f eature=youtube_ gdata&v=qw0SnIe 5MlE
Reply | Reply with quote | Quote
 

Add comment


Security code
Refresh